Remove 2003 Remove Compounding Remove FDA
article thumbnail

Pharmacist Involvement Helps Reduce Time to A1c Target

Drug Topics

J Am Pharm Assoc (2003). Sign up today for our free Drug Topics newsletter. References 1. Osunsanmi O, Schmitz N, Darkwah B, et al. Time to goal hemoglobin A1c with pharmacist management compared to non-pharmacist management. 2025 May 6:102413. doi: 10.1016/j.japh.2025.102413. 2025.102413. Epub ahead of print. PMID: 40339647.

article thumbnail

Elevating Pharmacy Technicians in Community Practice

Drug Topics

J Am Pharm Assoc (2003). I think a lot of pharmacists know that and even some of the ones who maybe aren't as quick to acknowledge it for whatever reason also recognize that.” References 1. Fick G, Osei J, Kim S, et al. A narrative literature review: Community pharmacy technician well-being and its implications. 2025 May 9:102419.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Q&A: Prioritizing Pharmacy Technician Well-Being

Drug Topics

J Am Pharm Assoc (2003). READ MORE: Supporting the Well-Being of Community Pharmacy Technicians References 1. Fick G, Osei J, Kim S, et al. A narrative literature review: Community pharmacy technician well-being and its implications. 2025 May 9:102419. doi: 10.1016/j.japh.2025.102419. 2025.102419. Epub ahead of print. PMID: 40349976.

article thumbnail

Can psychedelics provide breakthrough in mental health?

pharmaphorum

The term ‘psychedelic treatments’ incorporates a broad spectrum of different compounds, from LSD, psilocybin and DMT, to MDMA, ibogaine and ketamine. The latter compound has already been approved for treatment-resistance depression as the product Spravato (esketamine), after being developed by Janssen.

article thumbnail

Does Medicare cover Ozempic?

The Checkup by Singlecare

Yet the Food and Drug Administration (FDA) hasn’t approved this GLP-1 agonist injection for weight loss. Instead, it’s FDA approved to improve glycemic control in adults with Type 2 diabetes and to reduce the risk of adverse cardiovascular events in adults with Type 2 diabetes and known heart disease.

article thumbnail

Targeting tumours with novel radiopharmaceuticals

European Pharmaceutical Review

With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use. This has been demonstrated recently with PLUVICTO ® , which was the first US Food and Drug Administration (FDA)-approved targeted radioligand therapy for eligible patients with prostate cancer.

article thumbnail

Is Mounjaro covered by Medicaid?

The Checkup by Singlecare

Legislation passed in 2003 prohibits Medicare from covering drugs prescribed specifically for weight loss, and while Medicaid has more flexibility here, not every state will cover them. Look into compounded options (but be careful). Mounjaro’s only on-label use is for diabetes, so Medicaid likely won’t cover it for obesity.